Ippolito G, Fusco FM, Di Caro A, Nisii C, Pompa MG, Thinus G, Pletschette M, Capobianchi MR: Facing the threat of highly infectious diseases in Europe: the need for a networking approach. Clin Microbiol Infect. 2009, 15: 706-710. 10.1111/j.1469-0691.2009.02876.x.
Article
CAS
PubMed
Google Scholar
Brouqui P, Puro V, Fusco FM, Bannister B, Schilling S, Follin P, Gottschalk R, Hemmer R, Maltezou HC, Ott K, Peleman R, Perronne C, Sheehan G, Siikamäki H, Skinhoj P, Ippolito G, EUNID Working Group: Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease. Lancet Infect Dis. 2009, 9: 301-311. 10.1016/S1473-3099(09)70070-2.
Article
PubMed
Google Scholar
Bannister B, Puro V, Fusco FM, Heptonstall J, Ippolito G, EUNID Working Group: Framework for the design and operation of high-level isolation units: consensus of the European Network of Infectious Diseases. Lancet Infect Dis. 2009, 9: 45-56. 10.1016/S1473-3099(08)70304-9.
Article
PubMed
Google Scholar
Sterk E: Filovirus Haemorrhagic Fever Guideline. 2008, Paris, France: Médecins Sans Frontières
Google Scholar
Ergonul O: Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res. 2008, 78: 125-131. 10.1016/j.antiviral.2007.11.002.
Article
CAS
PubMed
Google Scholar
Feldmann H, Geisbert TW: Ebola haemorrhagic fever. Lancet. 2011, 377: 849-862. 10.1016/S0140-6736(10)60667-8.
Article
PubMed
PubMed Central
Google Scholar
World Health Organization: WHO recommended surveillance standards, Second edition 2009. [http://www.who.int/csr/resources/publications/surveillance/WHO_CDS_CSR_ISR_99_2_EN/en/]
Pittalis S, Fusco FM, Lanini S, Nisii C, Puro V, Lauria FN, Ippolito G: Case definition for Ebola and Marburg haemorrhagic fevers: a complex challenge for epidemiologists and clinicians. New Microbiol. 2009, 32: 359-367.
PubMed
Google Scholar
Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, Hensley LE, Schoepp RJ, Norwood DA, Goba A, Fair JN, Kulesh DA: Comprehensive panel ofreal-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am JTrop Med Hyg. 2010, 82: 954-960. 10.4269/ajtmh.2010.09-0636.
Article
CAS
Google Scholar
Palacios G, Briese T, Kapoor V, Jabado O, Liu Z, Venter M, Zhai J, Renwick N, Grolla A, Geisbert TW, Drosten C, Towner J, Ju J, Paweska J, Nichol ST, Swanepoel R, Feldmann H, Jahrling PB, Lipkin WI: MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever. Emerg Infect Dis. 2006, 12: 692-695. 10.3201/eid1204.051515.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhai J, Palacios G, Towner JS, Jabado O, Kapoor V, Venter M, Grolla A, Briese T, Paweska J, Swanepoel R, Feldmann H, Nichol ST, Lipkin WI: Rapid molecular strategy for filovirus detection and characterization. J Clin Microbiol. 2007, 45: 224-226. 10.1128/JCM.01893-06.
Article
CAS
PubMed
Google Scholar
Poloni TR, Oliveira AS, Alfonso HL: Detection of dengue virus in saliva and urine by real time RT-PCR. Virol J. 2010, 7: 22-10.1186/1743-422X-7-22.
Article
PubMed
PubMed Central
Google Scholar
Bodur H, Akinci E, Ongürü P, Carhan A, Uyar Y, Tanrici A, Cataloluk O, Kubar : Detection of Crimean-Congo hemorrhagic fever virus genome in saliva and urine. Int J Infect Dis. 2010, 14: e247-249.
Article
PubMed
Google Scholar
Formenty P, Leroy EM, Epelboin A, Libama F, Lenzi M, Sudeck H, Yaba P, Allarangar Y, Boumandouki P, Nkounkou VB, Drosten C, Grolla A, Feldmann H, Roth C: Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis. 2006, 42: 1521-1526. 10.1086/503836.
Article
PubMed
Google Scholar
Domingo C, Yactayo S, Agbenu E Demanou M, Schulz AR, Daskalow K, Niedrig M: Detection of yellow fever 17D genome in urine. J Clin Microbiol. 2011, 49: 760-762. 10.1128/JCM.01775-10.
Article
PubMed
PubMed Central
Google Scholar
Grolla A, Jones SM, Fernando L, Strong JE, Ströher U, Möller P, Paweska JT, Burt F, Pablo Palma P, Sprecher A, Formenty P, Roth C, Feldmann H: The use of amobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola. PLoS Negl Trop Dis. 2011, 5: e1183-10.1371/journal.pntd.0001183.
Article
PubMed
PubMed Central
Google Scholar
Pettersson L, Klingström J, Hardestam J, Lundkvist A, Ahlm C, Evander M: Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome. Emerg Infect Dis. 2008, 14: 406-411. 10.3201/eid1403.071242.
Article
CAS
PubMed
PubMed Central
Google Scholar
Feldmann H, Jones SM, Daddario-DiCaprio KM, Geisbert JB, Ströher U, Grolla A, Bray M, Fritz EA, Fernando L, Feldmann F, Hensley LE, Geisbert TW: Effective post exposure treatment of Ebola infection. PLoS Pathog. 2007, 3: e2-10.1371/journal.ppat.0030002.
Article
PubMed
PubMed Central
Google Scholar
Geisbert TW, Daddario-DiCaprio KM, Williams KJ, Geisbert JB, Leung A, Feldmann F, Hensley LE, Feldmann H, Jones SM: Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates. J Virol. 2008, 82: 5664-5668. 10.1128/JVI.00456-08.
Article
CAS
PubMed
PubMed Central
Google Scholar
Geisbert TW, Hensley LE, Geisbert JB, Leung A, Johnson JC, Grolla A, Feldmann H: Postexposure treatment of Marburg virus infection. Emerg Infect Dis. 2010, 16: 1119-1122.
Article
PubMed
PubMed Central
Google Scholar
Tuffs A: Experimental vaccine may have saved Hamburg scientist from Ebola fever. BMJ. 2009, 338: b1223-10.1136/bmj.b1223.
Article
PubMed
Google Scholar
Papa A, Bozovi B, Pavlidou V: Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia. Emerg Infect Dis. 2002, 8: 852-854.
Article
PubMed
PubMed Central
Google Scholar
Enria DA, Briggiler AM, Fernandez NJ, Levis SC, Maiztegui JI: Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma. Lancet. 1984, 2: 255-256.
Article
CAS
PubMed
Google Scholar
Hoogstraal H: The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol. 1979, 15: 307-417.
Article
CAS
PubMed
Google Scholar
Enria DA, Briggiler AM, Sánchez Z: Treatment of Argentine hemorrhagic fever. Antiviral Res. 2008, 78: 132-139. 10.1016/j.antiviral.2007.10.010.
Article
CAS
PubMed
Google Scholar
Vassilenko SM, Vassilev TL, Bozadjiev LG, Bineva IL, Kazarov GZ: Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever. Lancet. 1990, 335: 791-792.
Article
CAS
PubMed
Google Scholar
Mupapa K, Massamba M, Kibadi K, Kuvula K, Bwaka A, Kipasa M, Colebunders R, Muyembe-Tamfum JJ: Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J Infect Dis. 1999, 179 (Suppl 1): 18-23.
Article
Google Scholar
Jahrling PB, Geisbert JB, Swearengen JR, Larsen T, Geisbert TW: Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates. J Infect Dis. 2007, 196 (Suppl 2): 400-403.
Article
Google Scholar
Nakayama E, Tomabechi D, Matsuno K, Kishida N, Yoshida R, Feldmann H, Takada A: Antibody-dependent enhancement of Marburg virus infection. J Infect Dis. 2011, 204 (Suppl 3): 978-985. 10.1093/infdis/jir334.
Article
Google Scholar
Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I: Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA. J Virol Methods. 2010, 163: 205-209. 10.1016/j.jviromet.2009.09.018.
Article
CAS
PubMed
Google Scholar
Geisbert TW, Hensley LE, Kagan E, Yu EZ, Geisbert JB, Daddario-DiCaprio K, Fritz EA, Jahrling PB, McClintock K, Phelps JR, Lee AC, Judge A, Jeffs LB, MacLachlan I: Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference. J Infect Dis. 2006, 193: 1650-1657. 10.1086/504267.
Article
CAS
PubMed
Google Scholar
Geisbert TW, Lee AC, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, de Jong S, Tavakoli I, Judge A, Hensley LE, Maclachlan I: Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet. 2010, 375: 1896-1905. 10.1016/S0140-6736(10)60357-1.
Article
CAS
PubMed
Google Scholar
Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A, Maidhof H, Gouvras G, Task Force on Biological and Chemical Agent Threats, Public Health Directorate, European Commission, Luxembourg: Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses. Euro Surveill. 2004, 9: E11-12.
PubMed
Google Scholar
McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliott LH, Belmont-Williams R: Lassa fever: effective therapy with ribavirin. N Engl J Med. 1986, 314: 20-26. 10.1056/NEJM198601023140104.
Article
CAS
PubMed
Google Scholar
Holmes GP, McCormick JB, Trock SC, Chase RA, Lewis SM, Mason CA, Hall PA, Brammer LS, Perez-Oronoz GI, McDonnell MK: Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med. 1990, 323: 1120-1123. 10.1056/NEJM199010183231607.
Article
CAS
PubMed
Google Scholar
Huggins JW, Hsiang CM, Cosgriff TM, Guang MY, Smith JI, Wu ZO, LeDuc JW, Zheng ZM, Meegan JM, Wang QN: Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis. 1991, 164: 1119-1127. 10.1093/infdis/164.6.1119.
Article
CAS
PubMed
Google Scholar
Paragas J, Whitehouse CA, Endy TP, Bray M: A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. Antiviral Res. 2004, 62: 21-25. 10.1016/j.antiviral.2003.11.006.
Article
CAS
PubMed
Google Scholar
Sharifi-Mood B, Metanat M, Ghorbani-Vaghei A, Fayyaz-Jahani F, Akrami E: The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study. Arch Iran Med. 2009, 12: 151-153.
PubMed
Google Scholar
Koksal I, Yilmaz G, Aksoy F, Aydin H, Yavuz I, Iskender S, Akcay K, Erensoy S, Caylan R, Aydin K: The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J Clin Virol. 2010, 47: 65-68. 10.1016/j.jcv.2009.11.007.
Article
CAS
PubMed
Google Scholar
Koksal I, Yilmaz G, Aksoy F, Aydin H, Yavuz I, Iskender S, Akcay K, Erensoy S, Caylan R, Aydin K: T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res. 2009, 82: 95-102. 10.1016/j.antiviral.2009.02.198.
Article
Google Scholar
Aman MJ, Kinch MS, Warfield K, Warren T, Yunus A, Enterlein S, Stavale E, Wang P, Chang S, Tang Q, Porter K, Goldblatt M, Bavari S: Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral Res. 2009, 83: 245-251. 10.1016/j.antiviral.2009.06.001.
Article
CAS
PubMed
Google Scholar
Lee AM, Pasquato A, Kunz S: Novel approaches in anti-arenaviral drug development. Virology. 2011, 411: 163-169. 10.1016/j.virol.2010.11.022.
Article
CAS
PubMed
Google Scholar
Shum D, Smith JL, Hirsch AJ, Bhinder B, Radu C, Stein DA, Nelson JA, Früh K, Djaballah H: High-content assay to identify inhibitors of dengue virus infection. Assay Drug Dev Technol. 2010, 8: 553-570. 10.1089/adt.2010.0321.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bolken TC, Laquerre S, Zhang Y, Bailey TR, Pevear DC, Kickner SS, Sperzel LE, Jones KF, Warren TK, Amanda Lund S, Kirkwood-Watts DL, King DS, Shurtleff AC, Guttieri MC, Deng Y, Bleam M, Hruby DE: Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses. Antivir Res. 2006, 69: 86-97. 10.1016/j.antiviral.2005.10.008.
Article
CAS
PubMed
Google Scholar
Basu A, Li B, Mills DM, Panchal RG, Cardinale SC, Butler MM, Peet NP, Majgier-Baranowska H, Williams JD, Patel I, Moir DT, Bavari S, Ray R, Farzan MR, Rong L, Bowlin TL: Identification of a small-molecule entry inhibitor for filoviruses. J Virol. 2011, 85: 3106-3119. 10.1128/JVI.01456-10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Urata S, Yun N, Pasquato A, Paessler S, Kunz S, de la Torre JC: Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease. J Virol. 2011, 85: 795-803. 10.1128/JVI.02019-10.
Article
CAS
PubMed
Google Scholar
Pasquato A, Rochat C, Burri DJ, Pasqual G, de la Torre JC, Kunz S: Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242. Virology. 2012, 423: 14-22. 10.1016/j.virol.2011.11.008.
Article
CAS
PubMed
Google Scholar
Vincent MJ, Sanchez AJ, Erickson BR, Basak A, Chretien M, Seidah NG, Nichol ST: Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1. J Virol. 2003, 77: 8640-8649. 10.1128/JVI.77.16.8640-8649.2003.
Article
CAS
PubMed
PubMed Central
Google Scholar
Geisbert TW, Hensley LE, Jahrling PB, Larsen T, Geisbert JB, Paragas J, Young HA, Fredeking TM, Rote WE, Vlasuk GP: Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet. 2003, 362: 1953-1958. 10.1016/S0140-6736(03)15012-X.
Article
CAS
PubMed
Google Scholar
Hensley LE, Stevens EL, Yan SB, Geisbert JB, Macias WL, Larsen T, Daddario-DiCaprio KM, Cassell GH, Jahrling PB, Geisbert TW: Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J Infect Dis. 2007, 196 (Suppl 2): 390-399.
Article
Google Scholar
Rankin LG, Austin DL: The use of activated protein C in severe Plasmodium falciparum malaria. Anaesth Intensive Care. 2007, 3: 428-32.
Google Scholar
Souza DG, Fagundes CT, Sousa LP, Amaral FA, Souza RS, Souza AL, Kroon EG, Sachs D, Cunha FQ, Bukin E, Atrasheuskaya A, Ignatyev G, Teixeira MM: Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection. Proc Natl Acad Sci USA. 2009, 106: 14138-14143. 10.1073/pnas.0906467106.
Article
CAS
PubMed
PubMed Central
Google Scholar
Assunção-Miranda I, Amaral FA, Bozza FA, Fagundes CT, Sousa LP, Souza DG, Pacheco P, Barbosa-Lima G, Gomes RN, Bozza PT, Da Poian AT, Teixeira MM, Bozza MT: Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB J. 2010, 24: 218-228. 10.1096/fj.09-139469.
Article
PubMed
Google Scholar
Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS, Lin YS, Wang ST, Shyu HW, Yeh TM: Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg. 2006, 74: 142-147.
CAS
PubMed
Google Scholar
Michelow IC, Dong M, Mungall BA, Yantosca LM, Lear C, Ji X, Karpel M, Rootes CL, Brudner M, Houen G, Eisen DP, Kinane TB, Takahashi K, Stahl GL, Olinger GG, Spear GT, Ezekowitz RA, Schmidt EV: A novel l-ficolin/mannose-binding lectinchimeric molecule with enhanced activity against Ebola virus. J Biol Chem. 2010, 285: 24729-24739. 10.1074/jbc.M110.106260.
Article
CAS
PubMed
PubMed Central
Google Scholar
Seitsonen E, Hynninen M, Kolho E, Kallio-Kokko H, Pettilä V: Corticosteroids combined with continuous veno-venous hemodiafiltration for treatment of hantavirus pulmonary syndrome caused by Puumala virus infection. Eur J Clin Microbiol Infect Dis. 2006, 25: 261-266. 10.1007/s10096-006-0117-z.
Article
CAS
PubMed
Google Scholar
Krause R, Aberle S, Haberl R, Daxböck F, Wenisch C: Puumala virus infection with acute disseminated encephalomyelitis and multiorgan failure. Emerg Infect Dis. 2003, 9: 603-605.
Article
PubMed
PubMed Central
Google Scholar
Chang B, Crowley M, Campen M, Koster F: Hantavirus cardiopulmonary syndrome. Semin Respir Crit Care Med. 2007, 28: 193-200. 10.1055/s-2007-976491.
Article
PubMed
Google Scholar
Dietl CA, Wernly JA, Pett SB, Yassin SF, Sterling JP, Dragan R, Milligan K, Crowley MR: Extracorporeal membrane oxygenation support improves survival of patients with severe Hantavirus cardiopulmonary syndrome. J Thorac Cardiovasc Surg. 2008, 135: 579-584. 10.1016/j.jtcvs.2007.11.020.
Article
PubMed
Google Scholar
Pipeling MR, Fan E: Therapies for refractory hypoxemia in acute respiratory distress syndrome. JAMA. 2010, 304: 2521-2527. 10.1001/jama.2010.1752.
Article
CAS
PubMed
Google Scholar
Senior K: European lab network prepares for high-risk pathogen threat. Lancet Infect Dis. 2008, 8: 593-10.1016/S1473-3099(08)70215-9.
Article
Google Scholar
Sanchez A, Geisbert TW, Feldmann H: Filoviridae: Marburg and Ebola viruses. Fields virology. 2006, Philadelphia, PA: Lippincott Williams & Wilkins, 1409-1448. 5
Google Scholar
Ippolito G, Nisii C, Capobianchi MR: Networking for infectious-disease emergencies in Europe. Nature Rev Microbiol. 2008, 6: 564-10.1038/nrmicro1896-c1.
Article
CAS
Google Scholar